Amongst sufferers with acute myeloid leukemia, Black race has been discovered to be an impartial prognostic issue for decrease survival outcomes, no...
Amongst sufferers experiencing persistent graft-versus-host illness (cGVHD), the transition of remedy with Niktimvo (axatilimab) to a dose of 0.6 milligrams per kilogram...
Amongst sufferers who have been newly identified with a number of myeloma, Kyprolis (carfilzomib) plus Revlimid (lenalidomide) and dexamethasone (KRd) was related...
Amog sufferers with beforehand untreated diffuse massive B-cell lymphoma (DLBCL), therapy with the CD20 and CD3 bispecific antibody odronextamab has been related...
